Monoglobus pectinilyticus

Information

Microbe Identification

Monoglobus pectinilyticus

Microbe id: PMDBM2021627
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Monoglobus pectinilyticus [1981510]
Taxonomy Genus: Monoglobus [2039302]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Monoglobus pectinilyticus

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Monoglobus pectinilyticus


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Monoglobus pectinilyticus distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Monoglobus pectinilyticus in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Monoglobus pectinilyticus

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗2.30923645210631mNGS
Kidney Failure, Chronic PRJNA449784🔗2.32088386346209mNGS
Kidney Failure, Chronic PRJEB65297🔗2.75235805890344mNGS
Kidney Failure, Chronic PRJEB65297🔗2.77513483647579mNGS
Arthritis, Juvenile PRJNA562467🔗-3.6049315212667616S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-3.6815715301837616S
Diarrhea PRJNA317326🔗-3.3605760137586116S
Colorectal Neoplasms PRJNA824020🔗-3.9272206902774716S
Colorectal Neoplasms PRJNA284542🔗-3.6756713762946316S
Colorectal Neoplasms PRJEB46665🔗-3.5791227253656316S
Colorectal Neoplasms PRJDB11845🔗-3.438681053172416S
Colorectal Neoplasms PRJNA731589🔗-2.52253066754699mNGS
Diabetes Mellitus, Type 1 PRJNA766410🔗3.4139959342635616S
Hepatitis, Autoimmune PRJNA556801🔗-3.2932198877761816S
Parkinson Disease PRJNA742875🔗-3.5677575193547416S
Parkinson Disease PRJNA588035🔗2.15705082029878mNGS
Parkinson Disease PRJNA588035🔗2.21353289543538mNGS
Colitis, Ulcerative PRJNA917086🔗-4.3831401883508716S
Colitis, Ulcerative PRJNA804422🔗-3.9064252170614716S
Colitis, Ulcerative PRJNA398089🔗-2.00345573715609mNGS
Spinal Cord Injuries PRJNA861246🔗-3.8330964897964416S
Hepatitis B, Chronic PRJNA872871🔗3.493491392566716S
Caliciviridae Infections PRJNA788674🔗-3.8267639412083416S
Hepatolenticular Degeneration PRJNA1038771🔗-3.0111191827113816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-2.7160787390847516S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-4.0025915288706516S
Prostatic Neoplasms PRJNA762994🔗-3.4541493640999416S
Emergence Delirium PRJNA797529🔗3.7044820476469816S
Crohn Disease PRJNA917086🔗-4.4164752422690816S
Crohn Disease PRJNA1156939🔗-3.941059507969316S
Crohn Disease PRJNA938107🔗-3.5107401202741716S
Crohn Disease PRJNA820056🔗-2.8530002632065516S
Crohn Disease PRJNA398089🔗-2.20672420255794mNGS
Crohn Disease PRJNA398089🔗-2.1792457247198mNGS
Crohn Disease PRJNA993675🔗2.64526272826618mNGS
Crohn Disease PRJNA993675🔗2.68376959283628mNGS
Psoriasis PRJNA574485🔗-3.9375834716511816S
Mastitis PRJNA667141🔗-3.7817266423071716S
Cholestasis PRJNA478781🔗-3.5472314569431516S
Endometriosis PRJNA715328🔗-3.9532755537581116S
Diabetic Retinopathy PRJNA857030🔗-4.3019415154691516S
Arthritis, Rheumatoid PRJNA753264🔗-3.8373163091113516S
Arthritis, Rheumatoid PRJNA786110🔗-3.6114975493961316S
Hepatitis C PRJNA328966🔗-3.3208945141469616S
Neuroblastoma PRJNA716780🔗-2.26455399376847mNGS
Neuroblastoma PRJNA716780🔗-2.26149308362482mNGS
Hematologic Neoplasms PRJNA777832🔗3.1286046382259116S
Irritable Bowel Syndrome PRJNA637763🔗-3.3976058465932416S
Irritable Bowel Syndrome PRJEB37924🔗3.33353302903525mNGS
Irritable Bowel Syndrome PRJEB37924🔗3.38263724688179mNGS
Alzheimer Disease PRJEB59009🔗-3.3496079824588816S
Atrial Fibrillation PRJNA728204🔗-3.6001213489209516S
Liver Cirrhosis PRJNA861246🔗-3.8634350861383416S
Cystic Fibrosis PRJNA314903🔗-3.34408769855776mNGS
Cystic Fibrosis PRJNA314903🔗-3.15487681052165mNGS
HIV Infections PRJDB11949🔗-3.7602564651954916S
HIV Infections PRJNA810567🔗-3.6662532748257716S
Autism Spectrum Disorder PRJEB42687🔗-3.7907720615081316S
Hand, Foot and Mouth Disease PRJNA843173🔗-3.6303280683479616S
Renal Insufficiency, Chronic PRJNA562327🔗2.8667057495006216S
Multiple Sclerosis PRJEB53481🔗-3.278295232121816S
Multiple Sclerosis PRJEB28543🔗3.06644999048072mNGS
Multiple Sclerosis PRJEB28543🔗3.10780392187093mNGS
Malaria PRJNA642859🔗-3.1763262919745516S
Breast Neoplasms PRJNA658160🔗-2.3295553058294816S
COVID-19 PRJNA769052🔗-3.2734617002130816S
COVID-19 PRJNA678695🔗-3.0592733102700516S
Sepsis PRJNA641414🔗-2.381050362433716S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Monoglobus pectinilyticus



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Monoglobus pectinilyticus



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Monoglobus pectinilyticus

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Monoglobus pectinilyticus


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Monoglobus pectinilyticus



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Monoglobus pectinilyticus

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Monoglobus pectinilyticus

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Monoglobus pectinilyticus

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Monoglobus pectinilyticus



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Monoglobus pectinilyticus


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Monoglobus pectinilyticus


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?